These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 17323338

  • 1. Fractalkine-CX3CR1 axis regulates tumor cell cycle and deteriorates prognosis after radical resection for hepatocellular carcinoma.
    Matsubara T, Ono T, Yamanoi A, Tachibana M, Nagasue N.
    J Surg Oncol; 2007 Mar 01; 95(3):241-9. PubMed ID: 17323338
    [Abstract] [Full Text] [Related]

  • 2. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.
    Brand S, Hofbauer K, Dambacher J, Schnitzler F, Staudinger T, Pfennig S, Seiderer J, Tillack C, Konrad A, Göke B, Ochsenkühn T, Lohse P.
    Am J Gastroenterol; 2006 Jan 01; 101(1):99-106. PubMed ID: 16405540
    [Abstract] [Full Text] [Related]

  • 3. The high expression of Fractalkine results in a better prognosis for colorectal cancer patients.
    Ohta M, Tanaka F, Yamaguchi H, Sadanaga N, Inoue H, Mori M.
    Int J Oncol; 2005 Jan 01; 26(1):41-7. PubMed ID: 15586223
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma.
    Hira E, Ono T, Dhar DK, El-Assal ON, Hishikawa Y, Yamanoi A, Nagasue N.
    Cancer; 2005 Feb 01; 103(3):588-98. PubMed ID: 15612021
    [Abstract] [Full Text] [Related]

  • 5. Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts.
    Isse K, Harada K, Zen Y, Kamihira T, Shimoda S, Harada M, Nakanuma Y.
    Hepatology; 2005 Mar 01; 41(3):506-16. PubMed ID: 15726664
    [Abstract] [Full Text] [Related]

  • 6. Fascin expression in progression and prognosis of hepatocellular carcinoma.
    Iguchi T, Aishima S, Umeda K, Sanefuji K, Fujita N, Sugimachi K, Gion T, Taketomi A, Maehara Y, Tsuneyoshi M.
    J Surg Oncol; 2009 Dec 01; 100(7):575-9. PubMed ID: 19697358
    [Abstract] [Full Text] [Related]

  • 7. Expression of p53, Bcl-2, VEGF, Ki67 and PCNA and prognostic significance in hepatocellular carcinoma.
    Stroescu C, Dragnea A, Ivanov B, Pechianu C, Herlea V, Sgarbura O, Popescu A, Popescu I.
    J Gastrointestin Liver Dis; 2008 Dec 01; 17(4):411-7. PubMed ID: 19104702
    [Abstract] [Full Text] [Related]

  • 8. Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1).
    Lucas AD, Bursill C, Guzik TJ, Sadowski J, Channon KM, Greaves DR.
    Circulation; 2003 Nov 18; 108(20):2498-504. PubMed ID: 14581400
    [Abstract] [Full Text] [Related]

  • 9. Better survival in women with resected hepatocellular carcinoma is not related to tumor proliferation or expression of hormone receptors.
    Ng IO, Ng M, Fan ST.
    Am J Gastroenterol; 1997 Aug 18; 92(8):1355-8. PubMed ID: 9260806
    [Abstract] [Full Text] [Related]

  • 10. Involvement of interaction between Fractalkine and CX3CR1 in cytotoxicity of natural killer cells against tumor cells.
    Zhang X, Wei H, Wang H, Tian Z.
    Oncol Rep; 2006 Feb 18; 15(2):485-8. PubMed ID: 16391873
    [Abstract] [Full Text] [Related]

  • 11. Lack of association between the functional CX3CR1 polymorphism V249I and hepatocellular carcinoma.
    Mühlbauer M, Ringel S, Hartmann A, Lallinger G, Weiss TS, Gäbele E, Wünsch PH, Schölmerich J, Hellerbrand C.
    Oncol Rep; 2005 May 18; 13(5):957-63. PubMed ID: 15809764
    [Abstract] [Full Text] [Related]

  • 12. Proinflammatory role of fractalkine (CX3CL1) in rheumatoid arthritis.
    Blaschke S, Koziolek M, Schwarz A, Benöhr P, Middel P, Schwarz G, Hummel KM, Müller GA.
    J Rheumatol; 2003 Sep 18; 30(9):1918-27. PubMed ID: 12966591
    [Abstract] [Full Text] [Related]

  • 13. Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival.
    Nakai S, Masaki T, Shiratori Y, Ohgi T, Morishita A, Kurokohchi K, Watanabe S, Kuriyama S.
    Int J Oncol; 2002 Apr 18; 20(4):769-75. PubMed ID: 11894123
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical significance of combination study of apoptotic factors and proliferating cell nuclear antigen in estimating the prognosis of hepatocellular carcinoma.
    Osada S, Saji S, Kuno T.
    J Surg Oncol; 2004 Jan 18; 85(1):48-54. PubMed ID: 14696087
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma.
    Sasaki A, Tanaka F, Mimori K, Inoue H, Kai S, Shibata K, Ohta M, Kitano S, Mori M.
    Eur J Surg Oncol; 2008 Feb 18; 34(2):173-9. PubMed ID: 17928188
    [Abstract] [Full Text] [Related]

  • 20. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
    Li T, Zhu Y, Qin CY, Yang Z, Fang A, Xu S, Ren W.
    J Clin Pathol; 2012 Sep 18; 65(9):808-14. PubMed ID: 22734007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.